| Date Filed | Type | Description |
| 05/10/2023 |
4
| HAUSMAN DIANA (Director) has filed a Form 4 on Zentalis Pharmaceuticals, Inc.|
Txns:
| Granted 39,732 shares
@ $0 |
|
| 05/10/2023 |
3
| HAUSMAN DIANA (Director) has filed a Form 3 on Zentalis Pharmaceuticals, Inc. |
| 06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| HAUSMAN DIANA (Director) has filed a Form 4 on Immuneering Corp|
Txns:
| Granted 25,200 options
@ $13, valued at
$327.6k
|
|
| 01/18/2022 |
3
| HAUSMAN DIANA (Director) has filed a Form 3 on Immuneering Corp |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Sold 6,032 shares
@ $55.1187, valued at
$332.5k
Exercised 2,850 options to buy
@ $9.82, valued at
$28k
Exercised 3,182 options to buy
@ $11.84, valued at
$37.7k
|
|
| 12/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2020 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Exercised 10,000 shares
@ $15.74, valued at
$157.4k
Exercised 10,000 shares
@ $17.15, valued at
$171.5k
Sold 40,000 shares
@ $45, valued at
$1.8M
Exercised 10,000 options to buy
@ $0
Exercised 10,000 options to buy
@ $9.82, valued at
$98.2k
Exercised 10,000 options to buy
@ $11.84, valued at
$118.4k
|
|
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2020 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 332 shares
@ $19.54, valued at
$6.5k
|
|
| 07/10/2019 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 520 shares
@ $12.49, valued at
$6.5k
|
|
| 01/10/2019 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.|
Txns:
| Granted 499 shares
@ $12.48, valued at
$6.2k
Granted 75,000 options to buy
@ $15.53, valued at
$1.2M
|
|
| 01/02/2019 |
3
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 3 on Zymeworks Inc. |
| 09/28/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2015 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Oncothyreon Inc.|
Txns:
| Bought 5,747 shares
@ $4.65, valued at
$26.7k
|
|
| 12/16/2014 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Oncothyreon Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.76, valued at
$264k
|
|
| 12/16/2013 |
4
| HAUSMAN DIANA (Chief Medical Officer) has filed a Form 4 on Oncothyreon Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.74, valued at
$261k
|
|
| 12/14/2012 |
3/A
| Form 3 - Initial statement of beneficial ownership of securities [amend] |
| 12/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/11/2012 |
3
| HAUSMAN DIANE (Chief Medical Officer) has filed a Form 3 on Oncothyreon Inc. |